Rejuveron Life Sciences Funding: $75M Raised, Series B
Rejuveron Life Sciences is based in Zurich, Switzerland. It has raised $75M in total funding. Latest round: Series B.
Rejuveron Life Sciences funding overview
Rejuveron Life Sciences is based in Zurich, Switzerland. Rejuveron Life Sciences has raised $75M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in September 2023. The round record for Rejuveron Life Sciences runs through 2023; nothing later has been disclosed. Investors on record include Catalio Capital Management, Apeiron Investment Group, Mubadala Capital. 3 distinct backers are named across the disclosed rounds.
Rejuveron Life Sciences at a glance
Total raised
$75M
Latest round
Series B
Latest round date
September 2023
Headquarters
Zurich, Switzerland
Notable investors
Catalio Capital Management, Apeiron Investment Group, Mubadala Capital
Frequently asked about Rejuveron Life Sciences funding
How much has Rejuveron Life Sciences raised?
Rejuveron Life Sciences has raised $75M in total disclosed funding across the rounds on record.
Who has invested in Rejuveron Life Sciences?
Catalio Capital Management, Apeiron Investment Group, Mubadala Capital are named among the investors backing Rejuveron Life Sciences.
What was the latest Rejuveron Life Sciences funding round?
The most recent disclosed round is a Series B, announced in September 2023.
Where is Rejuveron Life Sciences based?
Rejuveron Life Sciences is based in Zurich, Switzerland.
When did Rejuveron Life Sciences last raise?
The last disclosed Rejuveron Life Sciences round closed in September 2023 at Series B.
We update the Rejuveron Life Sciences record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Zurich and their backers are listed below.
